SEC Form 4 · accession 0000914190-15-000418
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Moshe Pinto
Director
Period of report
Sep 9, 2015
Accepted (ET)
Sep 11, 2015 · 5:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 9, 2015 | A | 8,717 | $0.00 | A | 8,717 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.45 | holding | — | — | — | — | Aug 14, 2025 | Common Stock | 59,155 | 59,155 | D |
Explanation of responses
- F1On September 9, 2015, the Company granted 8,717 shares of restricted stock of the Company (the "Restricted Stock") in respect of the service by Mr. Pinto as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan. The Restricted Stock vests 6 months following the grant date.
- F2Options to purchase 19,719 shares vest on 8/14/16 and options to purchase 19,718 shares vest on each of 8/14/17 and 8/14/18.